{"id":"W4415942417","doi":"10.1016/j.annonc.2025.08.1754","title":"1117P Durvalumab plus carboplatin/paclitaxel followed by durvalumab for endometrial cancer: Tumour mutational burden-high subpopulation efficacy analyses from the DUO-E trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Durvalumab; Clinical trial; Endometrial cancer; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001904954,0.0006739734,0.00178137,0.0001769939,0.0002206994,0.000742579,0.0003598605,0.0004791076,0.001663903],"category_scores_gemma":[0.001788012,0.000281405,0.001859531,0.0003144089,0.0004271739,0.00059095,0.0003769173,0.001788355,0.0002690607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007057425,"about_ca_system_score_gemma":0.0006340874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001032617,"about_ca_topic_score_gemma":0.004283379,"domain_scores_codex":[0.9991776,0.000504871,0.00004070591,0.0001108901,0.00006276507,0.0001030471],"domain_scores_gemma":[0.9992872,0.0002656904,0.0001376025,0.000104144,0.00003684837,0.0001685574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8346692,0.002768765,0.02182456,0.00100436,0.01351757,0.0001442542,0.0001859308,0.003050352,0.006767347,0.000692717,0.002782629,0.1125923],"study_design_scores_gemma":[0.6364834,0.1594347,0.1484863,0.0003052125,0.03041758,0.0008051894,0.0003735091,0.006171559,0.003707576,0.002697243,0.01099134,0.0001264782],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933902,0.003758521,0.0002556562,0.0003029381,0.00007663646,0.000162135,0.0006492368,0.0000193818,0.001385443],"genre_scores_gemma":[0.9960948,0.001267103,0.0003955408,0.0003246845,0.00006099861,0.000132563,0.001050312,0.00001059823,0.0006633791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001904954,"threshold_uncertainty_score":0.01007444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1522381565026054,"score_gpt":0.4728840045935657,"score_spread":0.3206458480909604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}